Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells (Q39663444)

13 September 2017

title

Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells (English)

1 reference

13 September 2017

0 references

hepatocellular carcinoma

1 reference

Tan Weifeng

1

1 reference

13 September 2017

Shen Feng

2

1 reference

13 September 2017

Luo Xiangji

3

1 reference

13 September 2017

Su Changqing

4

1 reference

13 September 2017

Qiu Zhiquan

5

1 reference

13 September 2017

Zeng Huazhong

6

1 reference

13 September 2017

Yan Peining

7

1 reference

13 September 2017

Yu Yong

8

1 reference

13 September 2017

Wu Mengchao

9

1 reference

13 September 2017

Jiang Xiaoqing

10

1 reference

13 September 2017

Lau Wan-Yee

11

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20739158

23 June 2024

publication date

23 August 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0944711310002254?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

https://api.elsevier.com/content/article/PII:S0944711310002254?httpAccept=text/plain

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

23 June 2024

1 reference

13 September 2017

volume

18

1 reference

13 September 2017

issue

2-3

1 reference

13 September 2017

page(s)

158-162

1 reference

High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis

23 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Cdc42 is crucial for the maturation of primordial cell junctions in keratinocytes independent of Rac1.

23 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

23 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity.

23 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

23 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.

23 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

23 June 2024

Systemic chemotherapy

9

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis

23 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Global cancer statistics, 2002

23 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells

23 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Alpha-tomatine inactivates PI3K/Akt and ERK signaling pathways in human lung adenocarcinoma A549 cells: effect on metastasis

23 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues

23 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Tanshinone IIA, an ingredient of Salvia miltiorrhiza BUNGE, induces apoptosis in human leukemia cell lines through the activation of caspase-3

23 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

A decade's studies on metastasis of hepatocellular carcinoma

23 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis

23 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression

23 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line

23 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells

23 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

Reversing effect of Tanshinone on malignant phenotypes of human hepatocarcinoma cell line

23 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells

23 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.PHYMED.2010.07.003

23 June 2024

Identifiers

1 reference

13 September 2017

1 reference